Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
European Union
MedTech
Illumina gets go-ahead from EU to part ways with Grail
The DNA sequencing giant still has the freedom to choose between selling the cancer blood test developer outright or pursuing an independent spinout.
Conor Hale
Apr 12, 2024 10:11am
EU orders Illumina to split from Grail as penance for $8B deal
Oct 12, 2023 11:14am
Edwards Lifesciences named the subject of EU antitrust probe
Sep 26, 2023 11:37am
Illumina sets deadline for proxy fight over board seats
Apr 21, 2023 10:35am
EU commission adopts proposal to delay MDR implementation
Jan 6, 2023 11:03am
Devicemakers cutting products amid new EU regulations: Reuters
Dec 19, 2022 10:45am